SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

DJ Vor Biopharma Larger IPO Prices at Top of Expectations

· 02/05/2021 07:00

By Colin Kellaher

Vor Biopharma Inc. on Friday said its upsized initial public offering of 9.83 million shares was priced at $18 each, at the high end of the expected range.

The Cambridge, Mass., cell-therapy company previously planned to sell 8.82 million shares at between $16 and $18 apiece in the IPO.

Vor said it expects gross proceeds of about $176.9 million, adding that it granted the underwriters a 30-day option to buy up to an additional 1.47 million shares.

Vor shares are due to begin trading Friday under the symbol VOR.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 05, 2021 07:00 ET (12:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.